LILIUM NV (LILM)

NL0015000F41 - Common Stock

0.052  -0.03 (-36.97%)

After market: 0.0564 +0 (+8.46%)

Fundamental Rating

1

Overall LILM gets a fundamental rating of 1 out of 10. We evaluated LILM against 65 industry peers in the Aerospace & Defense industry. Both the profitability and financial health of LILM have multiple concerns. LILM does not seem to be growing, but still is valued expensively.



0

1. Profitability

1.1 Basic Checks

LILM had negative earnings in the past year.
In the past year LILM has reported a negative cash flow from operations.
In the past 5 years LILM always reported negative net income.
LILM had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

LILM has a Return On Assets of -124.74%. This is amonst the worse of the industry: LILM underperforms 93.94% of its industry peers.
LILM has a Return On Equity of -1050.03%. This is amonst the worse of the industry: LILM underperforms 83.33% of its industry peers.
Industry RankSector Rank
ROA -124.74%
ROE -1050.03%
ROIC N/A
ROA(3y)-102.55%
ROA(5y)-98.21%
ROE(3y)-431.46%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for LILM so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

1

2. Health

2.1 Basic Checks

LILM has more shares outstanding than it did 1 year ago.
LILM has a better debt/assets ratio than last year.

2.2 Solvency

LILM has an Altman-Z score of -7.40. This is a bad value and indicates that LILM is not financially healthy and even has some risk of bankruptcy.
LILM has a Altman-Z score of -7.40. This is amonst the worse of the industry: LILM underperforms 90.91% of its industry peers.
LILM has a Debt/Equity ratio of 0.22. This is a healthy value indicating a solid balance between debt and equity.
With a decent Debt to Equity ratio value of 0.22, LILM is doing good in the industry, outperforming 74.24% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.22
Debt/FCF N/A
Altman-Z -7.4
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

LILM has a Current Ratio of 0.84. This is a bad value and indicates that LILM is not financially healthy enough and could expect problems in meeting its short term obligations.
LILM's Current ratio of 0.84 is on the low side compared to the rest of the industry. LILM is outperformed by 87.88% of its industry peers.
LILM has a Quick Ratio of 0.84. This is a bad value and indicates that LILM is not financially healthy enough and could expect problems in meeting its short term obligations.
LILM has a Quick ratio of 0.84. This is in the lower half of the industry: LILM underperforms 68.18% of its industry peers.
Industry RankSector Rank
Current Ratio 0.84
Quick Ratio 0.84

1

3. Growth

3.1 Past

LILM shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 11.14%, which is quite good.
EPS 1Y (TTM)11.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%98.26%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

The Earnings Per Share is expected to grow by 22.80% on average over the next years. This is a very strong growth
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y23.65%
EPS Next 2Y13.68%
EPS Next 3Y9.58%
EPS Next 5Y22.8%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. Valuation

4.1 Price/Earnings Ratio

LILM reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for LILM. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y13.68%
EPS Next 3Y9.58%

0

5. Dividend

5.1 Amount

No dividends for LILM!.
Industry RankSector Rank
Dividend Yield N/A

LILIUM NV

NASDAQ:LILM (11/5/2024, 8:00:02 PM)

After market: 0.0564 +0 (+8.46%)

0.052

-0.03 (-36.97%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)09-25 2024-09-25/bmo
Earnings (Next)12-27 2024-12-27/bmo
Inst Owners2.7%
Inst Owner Change-35.95%
Ins Owners0.06%
Ins Owner Change0%
Market Cap32.90M
Analysts76.36
Price Target1.64 (3053.85%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-16.77%
PT rev (3m)12.17%
EPS NQ rev (1m)11.54%
EPS NQ rev (3m)11.54%
EPS NY rev (1m)15.02%
EPS NY rev (3m)15.02%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.84
P/tB 0.85
EV/EBITDA N/A
EPS(TTM)-0.75
EYN/A
EPS(NY)-0.59
Fwd EYN/A
FCF(TTM)-0.44
FCFYN/A
OCF(TTM)-0.39
OCFYN/A
SpS0
BVpS0.06
TBVpS0.06
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -124.74%
ROE -1050.03%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-102.55%
ROA(5y)-98.21%
ROE(3y)-431.46%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.22
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 226.49%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.84
Quick Ratio 0.84
Altman-Z -7.4
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)208.53%
Cap/Depr(5y)208.96%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)11.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%98.26%
EPS Next Y23.65%
EPS Next 2Y13.68%
EPS Next 3Y9.58%
EPS Next 5Y22.8%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y2.35%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-17.61%
EBIT Next 3Y12.51%
EBIT Next 5Y24.34%
FCF growth 1Y2.26%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y9.96%
OCF growth 3YN/A
OCF growth 5YN/A